首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3578402篇
  免费   269019篇
  国内免费   8714篇
耳鼻咽喉   48935篇
儿科学   118723篇
妇产科学   99888篇
基础医学   503948篇
口腔科学   102210篇
临床医学   325474篇
内科学   697521篇
皮肤病学   82697篇
神经病学   294206篇
特种医学   139506篇
外国民族医学   1130篇
外科学   536327篇
综合类   79346篇
现状与发展   6篇
一般理论   1399篇
预防医学   278815篇
眼科学   81800篇
药学   265159篇
  10篇
中国医学   6970篇
肿瘤学   192065篇
  2018年   37639篇
  2017年   29168篇
  2016年   33549篇
  2015年   38164篇
  2014年   52503篇
  2013年   79578篇
  2012年   105837篇
  2011年   111815篇
  2010年   67253篇
  2009年   64442篇
  2008年   105248篇
  2007年   111566篇
  2006年   113382篇
  2005年   109218篇
  2004年   106062篇
  2003年   102137篇
  2002年   99002篇
  2001年   167444篇
  2000年   172084篇
  1999年   145618篇
  1998年   42063篇
  1997年   37583篇
  1996年   37596篇
  1995年   36507篇
  1994年   33796篇
  1993年   31741篇
  1992年   116055篇
  1991年   112623篇
  1990年   109361篇
  1989年   105922篇
  1988年   97690篇
  1987年   95970篇
  1986年   90770篇
  1985年   87010篇
  1984年   65144篇
  1983年   55687篇
  1982年   32991篇
  1981年   29649篇
  1979年   59698篇
  1978年   41865篇
  1977年   35569篇
  1976年   33169篇
  1975年   35363篇
  1974年   42347篇
  1973年   40385篇
  1972年   37746篇
  1971年   35264篇
  1970年   32487篇
  1969年   31077篇
  1968年   28398篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Introduction: The Hedgehog (HH) pathway constitutes a collection of signaling molecules which critically influence embryogenesis. In adults, however, the HH pathway remains integral to the proliferation, maintenance, and apoptosis of adult stem cells including hematopoietic stem cells.

Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.

Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease.  相似文献   

43.
44.
45.
We review the spectrum of cutaneous disorders associated with inflammatory and neoplastic plasmacytic pathology. Because plasma cells are derived from B‐lymphocytes our overview includes discussion of certain lymphoplasmacytic proliferations. It is structured along histopathological lines, addressing conditions characterized by (a) cutaneous plasma cell infiltrates, (b) deposits of plasma cell products or their derivatives in the skin and (c) miscellaneous, poorly understood cutaneous complications of plasmacytic disorders. Lesions arising primarily in the skin and those due to cutaneous involvement by multisystem disorders are addressed. The range includes a spectrum of tumefactive and circulatory manifestations. We highlight key clinical and pathological features of the different conditions and outline recent advances in our understanding of these entities. By emphasizing the dermatopathological characteristics of this spectrum of disorders we hope to hone the diagnostic accuracy of practitioners in the field.  相似文献   
46.
47.
BackgroundThe aim of this study was to estimate the prevalence of dental prosthetic treatment and to investigate the demographic, social, economic and medical factors associated with the use of fixed and removable dentures in a representative sample of adults living in France.MethodsThe data were obtained from the 2002–2003 Decennial Health Survey, a cross-sectional study of a representative sample of the population living in France, which included 29,679 adults. Information was collected by interview. The variables collected were fixed denture, removable denture, age, gender, number of children, area of residence, nationality, educational attainment, family social status, employment status, annual household income per capita, supplementary insurance, chronic disease, eyesight problems/glasses, hearing problems/hearing aids. Multinomial logistic regression models were used to study the relationship between prosthetic treatment and demographic, socioeconomic and medical characteristics unadjusted, adjusted for age and adjusted for all the characteristics.ResultsThe prevalence of prosthetic treatment was 34.6% (95% confidence interval (CI): [34.1; 35.2]) for fixed prosthetic dentures and 13.8% (95% CI: [13.4; 14.2]) for removable prosthetic dentures. We showed a gradient between educational attainment and removable dentures; the odds ratio adjusted for all the variables (aOR) associated with no or primary education compared to post-secondary education was 2.56; 95% CI: [2.09; 3.13]. When annual household income per capita was low, subjects were less likely to report fixed dentures (aOR = 0.68; 95% CI: [0.62; 0.75]) than those with high annual household income per capita. Individuals without insurance less often reported fixed dentures than those with private insurance. Those reporting chronic disease were less likely to report fixed dentures (aOR = 0.87; 95% CI: [0.79; 0.95]) but more likely to report removable dentures (aOR = 1.29; 95% CI: [1.17; 1.43]) than those without chronic disease.ConclusionThis study reveals social, economic and medical inequalities in fixed and removable prosthetic treatment among adults in France.  相似文献   
48.
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号